Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension

The effective therapy for pulmonary arterial hypertension (PAH) with inadequate clinical response is scarce except for lung transplantation when prostacyclin infusion is ineffective. The purpose of this study is to investigate the efficacy and safety of selexipag in addition to the infusion of prost...

Descripción completa

Detalles Bibliográficos
Autores principales: Momoi, Mizuki, Hiraide, Takahiro, Shinya, Yoshiki, Momota, Hiromi, Fukui, Shogo, Kawakami, Michiyuki, Fukuda, Keiichi, Kataoka, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819132/
https://www.ncbi.nlm.nih.gov/pubmed/35145843
http://dx.doi.org/10.1016/j.rmcr.2022.101592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819132/
https://www.ncbi.nlm.nih.gov/pubmed/35145843
http://dx.doi.org/10.1016/j.rmcr.2022.101592

Ejemplares similares